Literature DB >> 2616254

Pharmacokinetics of a single dose of ofloxacin in healthy elderly subjects using noncompartmental and compartmental models.

C M Rademaker1, R W Jones, L J Notarianni, A van Dijk, J H Glerum, J Verhoef.   

Abstract

The pharmacokinetics of ofloxacin following a single 200 mg oral dose were studied in twelve healthy elderly volunteers. Relevant pharmacokinetic parameters were analysed by both noncompartmental and compartmental models. In compartmental analysis, the data on plasma concentrations was best described by an open two-compartment model. A zero-order absorption behaviour was found in some volunteers. The terminal half-lives were slightly prolonged and ranged from 6.2-11.6 h. A linear relationship was found between the renal clearance of the drug and the estimated creatinine clearance. Computer predictions of a multiple 200 mg dose regimen showed no important accumulation of ofloxacin. The recommendation of some authors that, in general, ofloxacin dosage may be halved in the elderly could not be confirmed. This has to be determined through further clinical experience in elderly ill subjects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2616254     DOI: 10.1007/bf01959415

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  13 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Clinical research in the elderly: ethical and methodological considerations.

Authors:  J A Bell; F E May; R B Stewart
Journal:  Drug Intell Clin Pharm       Date:  1987-12

3.  Method for the determination of ofloxacin, a quinolone carboxylic acid antimicrobial, by high-performance liquid chromatography.

Authors:  L J Notarianni; R W Jones
Journal:  J Chromatogr       Date:  1988-10-14

4.  Clinical use of the quinolones.

Authors:  H C Neu
Journal:  Lancet       Date:  1987-12-05       Impact factor: 79.321

5.  Mean residence time in the body versus mean residence time in the central compartment.

Authors:  L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1985-10

6.  Noncompartmental determination of the steady-state volume of distribution for any mode of administration.

Authors:  D Perrier; M Mayersohn
Journal:  J Pharm Sci       Date:  1982-03       Impact factor: 3.534

7.  [Pharmacokinetics of ofloxacin in the elderly (65-85 years) with normal renal function after a single oral dose of 200 mg].

Authors:  P Veyssier; J B Fourtillan; J Modai; W Couet; M A Lefebvre; J P Darchis; M Vincent Du Laurier; A Bryskier
Journal:  Pathol Biol (Paris)       Date:  1986-06

8.  Bioavailability of new formulations of amoxicillin in relation to its absorption kinetics.

Authors:  W Hespe; J S Verschoor; M Olthoff
Journal:  Arzneimittelforschung       Date:  1987-03

9.  Ofloxacin pharmacokinetics in renal failure.

Authors:  J P Fillastre; A Leroy; G Humbert
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

Review 10.  Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Monk; D M Campoli-Richards
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

View more
  3 in total

1.  Pharmacokinetics of ofloxacin in elderly patients and in healthy young subjects.

Authors:  M Molinaro; P Villani; M B Regazzi; R Rondanelli; G Doveri
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 3.  Quinolone disposition in the elderly. Practical implications.

Authors:  I Nilsson-Ehle; B Ljungberg
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.